Loading...
GNH India Pharmaceuticals Limited — Actinomycin Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #5 for Actinomycin · $53.4K export value · DGFT Verified
GNH India Pharmaceuticals Limited is the #5 Indian exporter of Actinomycin with $53.4K in export value and 56 verified shipments. GNH India Pharmaceuticals Limited holds a 1.8% market share in Actinomycin exports across 4 countries. The company exports 11 pharmaceutical products worth $1.8M across 3 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $47.7K | 51 | 89.4% |
| ESTONIA | $2.7K | 2 | 5.1% |
| PERU | $2.6K | 2 | 4.9% |
| URUGUAY | $371 | 1 | 0.7% |
GNH India Pharmaceuticals Limited exports Actinomycin to 4 countries. The largest destination is BRAZIL accounting for 89.4% of GNH India Pharmaceuticals Limited's Actinomycin shipments, followed by ESTONIA (5.1%) and PERU (4.9%). These destinations reflect GNH India Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | BRAZIL | $24.6K | 25 |
| TO THE ORDER, | BRAZIL | $15.4K | 10 |
| WORLD MEDIC SERVICOS DE CONSULTORI | BRAZIL | $1.8K | 3 |
| TRADE FARMA ASSESSORIA EMPRESARIAL | BRAZIL | $1.1K | 2 |
| HOSPITAL SAO RAFAEL SA & WORLD MEDI | BRAZIL | $623 | 1 |
| ASSOC BENEF SIRIA | BRAZIL | $608 | 1 |
India exported $882.7K worth of Actinomycin through 933 shipments from 184 suppliers to 97 countries, serving 351 buyers globally. GNH India Pharmaceuticals Limited contributes $53.4K to this total, accounting for 1.8% of India's Actinomycin exports. GNH India Pharmaceuticals Limited ships Actinomycin to 4 countries through 13 buyers.
GNH India Pharmaceuticals Limited's average Actinomycin shipment value is $953 per consignment, based on 56 shipments totaling $53.4K. The largest destination is BRAZIL (89.4% of GNH India Pharmaceuticals Limited's Actinomycin exports).
GNH India Pharmaceuticals Limited ranks #5 among 184 Indian Actinomycin exporters with a 1.8% market share. The top 3 exporters are EUGIA PHARMA SPECIALITIES LIMITED ($250.0K), MYLAN LABORATORIES LIMITED ($200.0K), IKRIS PHARMA NETWORK PRIVATE LIMITED ($108.1K). GNH India Pharmaceuticals Limited processed 56 shipments to 4 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| Dacilon 0.5 MG Dactinomycin USP./0.5mg(B | $9.0K | 4 |
| Dacilon 0.5 MG Dactinomycin USP./0.5mg | $3.1K | 3 |
| DACILON 0.5 MG DACTINOMYCIN USP./0.5MG | $3.0K | 4 |
| DACILON 0.5 MG DACTINOMYCIN USP/0.5MG BRAND: DACILON | $2.7K | 4 |
| DACILON 0.5 MG DACTINOMYCIN USP/0.5MG M | $2.3K | 2 |
| Dacihal Dactinomycin /0.5mg(Brand : Dacihal)(TAX INV.# 6319 Dtd: 22.06.2024) | $2.3K | 1 |
| DACILON 0.5 MG DACTINOMYCIN USP./0.5MG B | $2.3K | 4 |
| DACILON 0.5 MG DACTINOMYCIN USP./0.5MG(BRAND DACILON)(TAX INV.6068 DT27.12.2023)VLS | $1.8K | 1 |
| DACILON 0 5 MG DACTINOMYCIN USP 0 5MG BRAND DACILON BATCH NO DMI2234AC VIALS NOS |
What GNH India Pharmaceuticals Limited must comply with to export Actinomycin to its top destination countries
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | IKRIS PHARMA NETWORK PRIVATE LIMITED | $108.1K | 103 | 1 | $1.0K |
| 4 | CELON LABORATORIES PRIVATE LIMITED | $67.3K | 16 | 10 | $4.2K |
| 5 | GNH INDIA PHARMACEUTICALS LIMITED ★ | $53.4K | 56 | 4 | $953 |
| 6 | VAMA LIFECARE PRIVATE LIMITED | $44.7K | 59 | 5 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 304 | 32.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 184 | 19.7% |
| DELHI AIR | 108 | 11.6% |
| Bombay Air | 82 | 8.8% |
| DELHI AIR CARGO ACC (INDEL4) | 62 | 6.6% |
| AHEMDABAD AIR | 21 | 2.3% |
| Bombay Air Cargo | 20 | 2.1% |
| Delhi Air | 18 | 1.9% |
GNH India Pharmaceuticals Limited also exports these advanced oncology products. Each links to the detailed product page.
Visual overview of India's actinomycin supplier profile for GNH India Pharmaceuticals Limited — top suppliers, destinations, pricing, and trade routes
GNH India Pharmaceuticals Limited exports 11 products worth $1.8M. Beyond Actinomycin, top products include Immunoglobulin, Pembrolizumab, Ustekinumab, Pazopanib, Lenvatinib. View the complete GNH India Pharmaceuticals Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Actinomycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for GNH India Pharmaceuticals Limited's Actinomycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
GNH India Pharmaceuticals Limited
Full Company Profile →
11 products · $1.8M total trade · 3 categories
| ONCO STAR SP ONCOLOGIA LTDA |
| BRAZIL |
| $574 |
| 1 |
| CAMILE XAVIER MACHADO ROHA DE OLIVE | BRAZIL | $566 | 1 |
| MARIA GABRIELLE DE CARVALHO NASCIME | BRAZIL | $543 | 1 |
| CPF DA PACIENTE MENOR | BRAZIL | $510 | 1 |
GNH India Pharmaceuticals Limited supplies Actinomycin to 13 buyers globally. The largest buyer is TO THE ORDER (BRAZIL), followed by TO THE ORDER, (BRAZIL) and WORLD MEDIC SERVICOS DE CONSULTORI (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| $1.7K |
| 3 |
| DACILON 0.5 MG DACTINOMYCIN USP./0.5MG BRAND DACILONTAX DOCUMENT 5943 DTD28.09.2023 | $1.7K | 1 |
GNH India Pharmaceuticals Limited exports 36 distinct Actinomycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Dacilon 0.5 MG Dactinomycin USP./0.5mg(B with 4 shipments worth $9.0K.
| $757 |
| 7 | VENUS REMEDIES LIMITED | $35.6K | 5 | 4 | $7.1K |
GNH India Pharmaceuticals Limited ranks #5 among 184 Indian Actinomycin exporters. Average shipment value of $953 compared to the market average of $4.8K. The closest competitors by value are IKRIS PHARMA NETWORK PRIVATE LIMITED and CELON LABORATORIES PRIVATE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 97+ countries, 351+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for GNH India Pharmaceuticals Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Actinomycin. For current shipment-level data, contact TransData Nexus.